Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
9.97
+0.14 (1.42%)
At close: Oct 29, 2024, 4:00 PM
9.80
-0.17 (-1.71%)
After-hours: Oct 29, 2024, 6:36 PM EDT
Lexeo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Oct '24 Oct 29, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 330 | 358 | - | - | - |
| Enterprise Value | 165 | 523 | - | - | - |
| Last Close Price | 9.97 | 13.42 | - | - | - |
| PE Ratio | - | -1.08 | - | - | - |
| PB Ratio | 2.00 | 3.15 | - | - | - |
| P/FCF Ratio | -8.33 | -6.00 | - | - | - |
| P/OCF Ratio | -8.39 | -6.01 | - | - | - |
| EV/EBITDA Ratio | -4.23 | -7.70 | - | - | - |
| EV/EBIT Ratio | -4.20 | -7.64 | - | - | - |
| EV/FCF Ratio | -5.43 | -8.78 | - | - | - |
| Debt / Equity Ratio | 0.07 | 0.10 | 0.19 | - | - |
| Debt / FCF Ratio | -0.17 | -0.20 | -0.24 | - | - |
| Asset Turnover | - | - | 0.01 | 0.02 | - |
| Quick Ratio | 9.27 | 7.05 | 5.39 | 18.24 | 42.10 |
| Current Ratio | 9.38 | 7.21 | 5.58 | 18.35 | 42.15 |
| Return on Equity (ROE) | -74.83% | -71.54% | -58.84% | -65.27% | - |
| Return on Assets (ROA) | -39.93% | -36.15% | -32.33% | -38.07% | - |
| Return on Capital (ROIC) | -44.64% | -40.64% | -35.18% | -40.81% | - |
| Earnings Yield | -23.43% | -18.57% | - | - | - |
| FCF Yield | -19.24% | -16.67% | - | - | - |
| Buyback Yield / Dilution | -1114.55% | -228.42% | -5.00% | -7.72% | - |
| Total Shareholder Return | -1114.55% | -228.42% | -5.00% | -7.72% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.